SavedAdd your journal

Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2011 / Cilt: 16 - Sayı: 1

Batı Nil virüsü infeksiyonları

West Nile virus infections

Koçak Zeliha TUFAN
Cemal BULUT
Pages
1–9
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is no specific therapy for West Nile virus infection and the principal therapy is mainly symptomatic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:West Nile virus may cause a wide range of clinical presentations ranging from asymptomatic cases to fatal outcomes.
📊
Key Findings & Data:Since it has been seen in Turkey and neighboring areas in recent years, it has attracted increased attention.
💡
Conclusion & Impact:There is no specific therapy for West Nile virus infection and the principal therapy is mainly symptomatic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

West Nile virus may cause a wide range of clinical presentations ranging from asymptomatic cases to fatal outcomes. Since it has been seen in Turkey and neighboring areas in recent years, it has attracted increased attention. The virus can cause West Nile fever and West Nile neuroinvasive disease, which includes meningitis, encephalitis and acute flaccid paralysis. Diagnosis is made by virus culture, polymerase chain reaction and ELISA. There is no specific therapy for West Nile virus infection and the principal therapy is mainly symptomatic.

Özet

Batı Nil virüsü, asemptomatik infeksiyondan ölümcül seyreden ensefalite kadar farklı kliniklerle karşımıza çıkabilen, salgınlara neden olabilen bir virüstür. Son yıllarda Türkiye'de ve çevre ülkelerde yaz aylarında görülmeye başlanmış olması dikkatleri bu virüse çekmiştir. Virüs, Batı Nil ateşine ve menenjit, ensefalit ve akut flask paraliziyi içeren Batı Nil nöroinvaziv hastalıklarına neden olabilmektedir. Tanıda virüsün izolasyonu, polimeraz zincir reaksiyonu ve ELISA kullanılabilmektedir. Tedavide yeni gelişmeler olmakla birlikte spesifik bir tedavisi yoktur. Semptomatik ve destek tedavi esastır.

🔖

Cite This Article

TUFAN, K. Z., BULUT, C. (2011). Batı Nil virüsü infeksiyonları. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 16 - Sayı: 1, 1–9. https://ajindex.com/articles/203616

References (13)

  1. Chowers M. West Nile fever. In: Schwartz E (ed). Tropical Diseases in Travelers. 1st ed. Singapore: Blackwell Publishing, 2009:65-73
  2. Green S, Rothman AL. West Nile virus. In: Gorbach SL, Bart-lett JG, Blacklow NR (eds). Infectious Diseases. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004:2128-32
  3. West Nile virus circulation in the EpiSouth countries and neighbouring areas (Hungary and Russia) Update 6th of October 2010. Accessed: 22 March 2011. Available from:
  4. West Nile virus. Information and guidance for clinicians. Accessed: 20 March 2011. Available from: http:// www.cdc.gov/ncidod/dvbid/westnile/clinicians/pdf/wnv-epidemiology-clinguidance.pdf 5. Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med 2010;30:47-65
  5. Chu JJ, Ng ML. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells, J Biol Chem 2004;279:54533-41
  6. Chu JJ, Ng ML. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 2004;78:10543-55
  7. Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbe-ta3 integrin. J Virol 2008;82:5212-9
  8. West Nile Fever. European Centre for Disease Prevention and Control. Accessed: 10 March 2011. Available from: http://www. ecdc. europa. eu/en/healthtopics/west_nile_fever/Pages/index, aspx 10. Epidemic/Epizootic West Nile Virus in the United States: Guidelines for Surveillance, Prevention and Control. Accessed: 10 March 2011. Available from:
  9. Han LL, Popovici F, Alexander JP Jr, Laurentia V, Tengelsen LA, Cernescu C, et al. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.J Infect Dis 1999;179:230-3
  10. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu Nl. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998;352:767-71
  11. Nash D, Mostashari F, Fine A, MillerJ, O'Leary D, Murray K, et al; 1999 West Nile Outbreak Response Working Croup. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14
  12. Chowers MY, Lang R, Nassar F, Ben-David D, Ciladi M, Rubinshtein E, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8
  13. Serter D. Flaviviruslar. In: Wlllke Topçu A, Söylet